![{[setting('site_name')]}](https://projxnews.com/uploads/setting/16983847711140531930.webp)
J M Chemicals is developing a new Bulk Drugs and Intermediates Project in Panoli, Gujarat. The project, which is planned to be finished in 2024, will manufacture a variety of bulk pharmaceuticals and intermediates for both domestic and foreign markets. J M Chemicals has made a large investment in the project, which is projected to create jobs in the region. The project's budget is 5 crores. The project is also expected to have a number of other benefits, including: Economic benefits: The project will boost the local economy and provide employment opportunities for people in the area. Industrial benefits:
The new facility will help to strengthen India's position as a global leader in bulk drug and intermediate manufacturing. Manufacturing benefits: The new facility will increase the availability of high-quality bulk drugs and intermediates in India and around the world. I am confident that the new Bulk Drugs & Intermediates Project at Panoli, Bharuch, Gujarat will be a success and will have a positive impact on the region and the Indian bulk drug and intermediate industry as a whole. Creative response Imagine a world where everyone has access to the medicines they need, regardless of their income or location. J M Chemicals is helping to make this world a reality with its new Bulk Drugs & Intermediates Project at Panoli, Bharuch, Gujarat. Bulk drugs and intermediates are essential for the production of medicines.
The new project will increase the availability of these essential materials, making medicines more affordable and accessible for everyone. The new project is also good news for the Indian pharmaceutical industry. India is already a major exporter of bulk drugs and intermediates, and the new project will further strengthen India's position in the global market.
As of September 2023, The project is now in the stage of receiving approvals & has obtained all necessary government permissions work of the project is anticipated to occur in either 2023 or 2024.
News by Rahul Yeligetti
